Literature DB >> 23046372

Selective plasma exchange with dialysis in patients with acute liver failure.

Hajime Nakae1, Toshiko Igarashi, Kimitaka Tajimi.   

Abstract

Selective plasma exchange with dialysis is a blood purification therapy in which simple plasma exchange is performed using a selective membrane plasma separator while the dialysate flows out of the hollow fibers. To evaluate the effect of plasma exchange with dialysis, biochemical examination of the blood, for example, the oxidative stress regulation system and interleukin 18 levels, was performed in patients with acute liver failure. We studied four patients with acute liver failure in whom the therapy was performed (nine times in total). The degree of hepatic encephalopathy and interleukin 18 levels decreased significantly after treatment. However, total protein levels did not change significantly. The level of reactive oxygen species and total antioxidant capacity did not change significantly. Plasma exchange with dialysis may be a useful blood purification therapy in cases of acute liver failure in terms of the removal of water-soluble and albumin-bound toxins.
© 2012 The Authors. Therapeutic Apheresis and Dialysis © 2012 International Society for Apheresis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046372     DOI: 10.1111/j.1744-9987.2012.01112.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  4 in total

1.  A good response to glucocorticoid for sub-acute liver failure: a case report.

Authors:  Zhaohui Bai; Hongyu Li; Kexin Zheng; Jingqiao Zhang; Xintong Zhang; Jiao Deng; Zhe Jia; Xinmiao Zhou; Xiaozhong Guo; Xingshun Qi
Journal:  Transl Gastroenterol Hepatol       Date:  2018-05-03

2.  Liver dialysis in acute-on-chronic liver failure: current and future perspectives.

Authors:  Rakhi Maiwall; Jaswinder Singh Maras; Suman Lata Nayak; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2014-04-24       Impact factor: 6.047

3.  Plasma exchange in patients with acute and acute-on-chronic liver failure: A systematic review.

Authors:  Eunice Xiang-Xuan Tan; Min-Xian Wang; Junxiong Pang; Guan-Huei Lee
Journal:  World J Gastroenterol       Date:  2020-01-14       Impact factor: 5.742

4.  AMBAR, an Encouraging Alzheimer's Trial That Raises Questions.

Authors:  David A Loeffler
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.